Nabil Daoud, president of Lilly Spain, Portugal and Greece, highlights the importance of Lilly’s Spanish operations to the global group; Spain being the only country outside to hold manufacturing, pre-clinical research and commercial sales functionalities. Furthermore, he gives insight into his strategy to deliver the company’s exciting pipeline and his priorities and challenges in the future.
Spaniards are extremely proud and positive about their public healthcare service, and for good reason!
